Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 3/20 | 0.34 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16996483 | 0.97 | ALOX5 (0.48) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16996360 | 0.97 | ALOX5 (0.48) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL17816817 | 0.94 | ALOX5 (0.44) | ALOX5PRKDCPARP14 | |
| SCHEMBL26233244 | 0.94 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16996318 | 0.94 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL21141478 | 0.94 | ALOX5 (0.42) | ALOX5PRKDCPARP14 | |
| SCHEMBL16996321 | 0.93 | ALOX5 (0.45) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16133392 | 0.93 | ALOX5 (0.45) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL21368298 | 0.93 | ALOX5 (0.43) | ALOX5PRKDCPARP14 | |
| SCHEMBL19218469 | 0.92 | ALOX5 (0.44) | ALOX5PRKDCPARP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-11-29 | — | — | US | disclosed |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | OCIAD2, OCIAD1, SLC7A5 | ALOX5 963/4885PRKDC 3038/4885PARP14 1671/4885 |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | OCIAD2, OCIAD1, SLC7A5 | ALOX5 963/4885PRKDC 3038/4885PARP14 1671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.